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Abstract
Objective: The aim of this study is to evaluate how anxiety influences the burden of disease of cluster headache.
Methods: Participants completed a modified version of the EUROLIGHT questionnaire. Anxiety was measured with the
anxiety subscale of the Hospital Anxiety and Depression scale. An elevated level of anxiety was assumed when eight or
more points were scored. Results: The data of 1089 participants were taken for analysis. The score of the anxiety
subscale of the Hospital Anxiety and Depression Scale (HADS-A) correlated weakly with the number of attacks in the last
30 days (r ¼ 0.17). A score of eight and above in the HADS-A was associated with hurting oneself during an attack (odds
ratio (OR) ¼ 2.63), worrying about future attacks (OR ¼ 2.95) and reporting of both failed relationships (OR¼ 2.81) and
career problems (OR ¼ 2.65). The odds of feeling understood by family and friends as well as colleagues and employers
were lower in anxious persons (OR ¼ 0.35 and 0.40, respectively). Conclusions: Anxiety complicates dealing with
cluster headache and strongly aggravates its burden. Instead of finding help in others, anxious persons feel misunderstood
and withdraw; relationships fail and difficulties at work arise.
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Introduction
Anxiety disposes towards defensive behaviours.1–4 Indu-
cing preoccupation, restlessness, irritability, hypervigi-
lance and a sense of fear, it aims at increasing the odds
of surviving under threat.1–4
The extent of objective danger necessary to provoke
anxiety varies individually. Very low thresholds are the
prerequisite for anxiety disorders that are characterised
by a strong propensity towards defensive behaviour.1 They
impose a tremendous burden that often adds to that of co-
morbid diseases.5
Cluster headache (CH) and anxiety frequently co-occur
in the same individuals6–8; Jorge et al. found that an anxiety
disorder often preceded the onset of CH.6 While we do not
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know whether one condition causes the other, we expect
them to influence each other.
The aim of this study is to test the hypothesis of anxiety
affecting the burden of CH.
Methods
Design and sampling methods have already been pub-
lished.9,10 Patient associations and national headache soci-
eties in several European countries were notified about the
study and asked to inform patients. The study was cross-
sectional and Internet-based. A self-reported diagnosis of
CH and a residency in a European country were required
for participation. Before completing the questionnaire,
patients were informed about the purpose of the survey and
asked to provide informed consent.
Participants were included into further analysis if the
diagnosis could be validated according to the criteria pub-
lished by the International Headache Society.11 The survey
consisted of a modified version of the EUROLIGHT ques-
tionnaire.9,12 If at least one attack had occurred within 30
days prior to the survey participants with episodic CH were
considered ‘in-bout’. The National Research Ethics Com-
mittee Luxembourg had approved the study.
Anxiety was measured with the anxiety subscale of the
Hospital Anxiety and Depression Scale (HADS-A)13;
scores below eight points indicate the absence of an anxiety
disorder.14
Statistical analysis
We analysed the data using SPSS version 25 (IBM, USA).
Categorical variables are described as proportions, and
continuous variables as means and standard deviations.
We used a two-tailed 2 test to test for association. Corre-
lation between ordinate variables was measured using
two-tailed Spearman’s rho. The extent of association in
contingency tables was measured calculating odds ratios
(OR) and their 95% confidence intervals (CIs). Sixteen p
values were corrected for multiple testing according to
Bonferroni; values below 0.05 were considered as signifi-
cant. We will refer to missing data as ‘not reported’ (n.r.).
Results
The questionnaire was completed by 1514 individuals.9
The diagnosis of CH was validated in 1165 participants,
of whom 1089 (93.5%) responded all items of the HADS-
A, and data of only these participants were taken for further
analysis. Chronic CH was present in 233 participants
(21.4%).
Mean age was 42 + 11 years (five n.r.), 69.5% of the
participants were male (755 of 1087; 2 n.r.), 73.9% were
married or living with a partner (788 of 1067; 22 n.r.), and
79.5% were studying, employed or self-employed (851 of
1071; 18 n.r.). Table 1 summarises demographic data.
The median score reached in the HADS-A was eight;
Figure 1 depicts the frequency distribution.
Ictal burden
We refer to stresses and strains that occur during an attack
as ‘ictal burden’; it is opposed to the ‘interictal burden’ that
is present in the absence of acute headache. Interictal bur-
den may occur inside as well as outside cluster bouts.
Table 1. Numbers of participants and demographic characteristics per country.a







Austria 34 (3.1) 64.7 38.1 (9.0) 88.2 73.5
Belgium 29 (2.7) 69.9 42.5 (9.2) 82.1 85.2
Czech REPUBLIC – – – – –
Denmark 11 (1.0) 63.6 41.3 (15.8) 72.7 63.6
Finland 46 (4.2) 57.8 42.9 (13.0) 73.9 78.3
France 210 (19.3) 72.9 39.4 (10.3) 79.3 71.4
Germany 264 (24.3) 71.9 43.2 (9.7) 82.2 71.3
Ireland 5 (0.5) 60.0 47.0 (11.6) 80.0 100
Italy 81 (7.4) 70.4 40.2 (10.3) 91.3 85.2
Luxembourg 1 (0.1) 100 46 100.0 100
The Netherlands 16 (1.5) 62.5 40.9 (13.2) 81.3 68.8
Norway 18 (1.7) 61.1 39.8 (10.4) 81.3 77.8
Poland 8 (0.7) 62.5 46.8 (7.7) 75.0 50.0
Spain 90 (8.3) 78.9 39.1 (9.2) 76.7 78.4
Sweden 43 (3.9) 62.8 43.0 (13.2) 76.7 78.0
Switzerland 42 (3.9) 78.6 40.1 (11.2) 85.4 69.0
United Kingdom 191 (17.5) 62.8 46.3 (11.2) 70.9 71.4
Total 1089 69.5 42 (11) 79.5 73.9
HADS-A: anxiety subscale of the Hospital Anxiety and Depression Scale; SD: standard deviation.
aEven though participants from the Czech Republic had filled in the questionnaire,9 none of them completed the HADS-A.
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The score of the HADS-A correlated negatively with
disease duration (r¼0.09, p¼ 0.033) and positively with
the number of attacks in the last 30 days (r ¼ 0.17, p <
0.001). Scores of eight and more occurred more frequently
in chronic CH than in episodic (p¼ 0.037, OR¼ 1.58, 95%
CI 1.18–2.12; 50 n.r.). The frequency of scores above the
threshold did not differ significantly between the in-bout
and the out-bout period in episodic CH (p ¼ 0.974, OR ¼
0.76, 95% CI 0.57–1.01).
About one-third (36.2%; 384 of 1062; 27 n.r.) of the
participants reported having hurt themselves during an
attack. This was more common among those in whom the
HADS-A indicated an elevated anxiety level (OR ¼ 2.63,
95% CI 2.03–3.41, p < 0.001, 27 n.r.). In addition, patients
scoring eight or more were significantly more likely to have
sought medical advice of a general practitioner, a headache
specialist, or in an emergency department within the last
12 months (OR ¼ 1.85, 95% CI 1.45–2.37, p < 0.001).
Furthermore, in the group of participants taking preventive
drugs (50.1%; 546 of 1089), anxiety levels above the
threshold were more common (OR ¼ 1.55, 95% CI 1.22–
1.97, p ¼ 0.01).
Inter-ictal burden
Avoiding telling others about CH was reported by 51.1% of
the participants (542 of 1060; 28 n.r.); 77.5% (815 of 1051;
28 n.r.) felt that their family and friends accept and under-
stand their disease, and 54.2% (456 of 842; 247 n.r.) did not
feel understood by colleagues and employers.
Reduced earnings and an impaired career due to the
disease were reported by 58.0% (580 of 1000; 89 n.r.) and
58.6% (624/1064; 25 n.r.), respectively; 13.2% (134 of
1014; 75 n.r.) recounted a failed relationship, and 13.6%
(140 of 1028; 61 n.r.) declared having had less or no chil-
dren because of CH. The association between anxiety lev-
els and inter-ictal burden is summarised in Figure 2.
Discussion
A high level of anxiety affected half of the participants of
this study. It correlated, though weakly, with both the num-
ber of the attacks and disease duration. Given the small
correlation coefficient, it is unlikely that anxiety is just a
consequence of the number of suffered attacks – or vice
versa. This seconds the findings of Jorge et al. who con-
cluded from their data that an anxiety disorder frequently
preceded the first manifestation of CH.6 Anxiety and CH
must hence be viewed as co-morbidities.
While anxiety levels are significantly higher in chronic
than episodic CH, the influence of these subtypes on anxi-
ety is small. The association between anxiety and both
inter-ictal and cumulative burden is more marked (see Fig-
ure 2). Clearly, the repercussions of CH in daily life are
either more severe or experienced as more severe in the
presence of anxiety.
Donnet et al. investigated a large sample of 2074
patients suffering from chronic CH and found high levels
of anxiety in 75.7% of them.15 Other studies with consider-
ably smaller sample sizes reported anxiety to be present in
between 8% and 23.8% of patients with episodic CH and
between 11.8% and 19% of patients with chronic CH.8
Anxiety is not rare in thegeneral populationaswell.Using
the HADS-A, an elevated level of anxiety was identified in
21%.16Most likely, however, not all of them suffer from an
anxiety disorder. The 12-month prevalence of anxiety dis-
orders and of subthreshold anxiety disorders in the general








































Figure 1. Frequency distribution of the scores in the anxiety subscale of the Hospital Anxiety and Depression Scale; the vertical black
line indicates the cut-off above which an anxiety disorder is assumed. Eight or more points were reached by 50.6% of the participants.
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defined as recurrent psychopathological symptoms that are
typical for anxiety disorders but not sufficiently severe to
make the diagnosis. Evidently, when assessing anxiety, dif-
ferent measuring methods may yield different results.
The HADS-A was designed to quantify anxiety and not
to diagnose a specific disease.13 It focuses on the repercus-
sion of anxiety on mood and – to a lesser extent – on
behaviour and cognition.3 Yet, a score of eight and more
hints at a generalised anxiety disorder (GAD) with a sensi-
tivity of 89% and a specificity of 75%.19 Thus, many par-
ticipants who reached higher scores probably suffered from
GAD. This could explain why the disease state (in-bout/
out-bout, episodic/chronic) influences anxiety levels little.
Long-lasting and pervasive worrying is the hallmark of
GAD.4 Often, though, worrying is not recognised as an
issue by patients suffering from that disorder; contrarily,
they tend to see it as a helpful instrument to prevent unplea-
sant experiences.20 What they commonly do is complain
about physical symptoms, particularly chronic pain.4 The
reason for the latter is unknown; studies suggest that anxi-
ety does not affect the pain threshold.21,22
Anxiety may be linked to a sense of helplessness.4 That
feeling perhaps explains the higher odds of consulting doc-
tors in the group of anxious persons. Seeking medical
advice might be a way to cope with helplessness, given that
family, friends, colleagues and employers often do not
seem to understand and accept their disease.
Loneliness, work loss and reduced productiveness at
work can be associated with GAD.23,24 Therefore, we must
consider that not CH but anxiety compromised relation-
ships, understanding by others and job opportunities. Not
only relations to others may be troubled; anxious persons
often are not safe from themselves either. Patients suffering
from anxiety disorders are prone for self-harm.25 Concor-
dantly, in our study, people with higher levels of anxiety
report hurting themselves during CH attacks more fre-
quently. In addition, both anxiety disorders and CH are
associated with a higher likelihood of suicidality.25,26 Thus,
Figure 2. Differences in inter-ictal burden between patients who scored less than eight points and those who scored eight points and
more in the HADS-A. An OR below 1.0 indicates that we found higher odds for that attribute to be present in participants with lower
scores. Conversely, an OR higher than 1.0 indicates that the odds are higher for participants with higher scores. The reported p values
were corrected for multiple testing. OR: odds ratio; CI: confidence interval; HADS-A: anxiety subscale of the Hospital Anxiety and
Depression Scale.
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suicidal ideation should be assessed regularly in anxious
patients with CH.
The strengths of this study are the large sample size and
the rather high number of countries of origin of the parti-
cipants. Some limitations should be noted. Firstly, as stated
before,9 it is likely that women and patients with chronic
CH were over-represented. Secondly, the self-reported
diagnosis of CHmight lead to a measuring bias. Addressing
that issue, we included only patients whose diagnosis could
be validated based upon their responses in the question-
naire. Thirdly, the sample is not population based. There-
fore, we cannot deduce prevalence and incidence from our
data. Instead, we focused on studying subgroups and their
relationships. Finally, the study design does not allow con-
clusions about cause and effect.
Conclusions
Anxiety is a physiological reaction to threat that aims at
reducing danger by increasing vigilance and preparing for
escape. It is based upon the notion of being confronted with
stronger forces that make offensives futile.
When anxious persons are struck with CH, their reaction
comprises worrying and the attempt to avoid potential trig-
gers. Instead of finding help in others, they feel misunder-
stood and withdraw; relationships fail and difficulties at
work arise. Anxiety complicates dealing with CH and
aggravates its burden. Therefore, we recommend screening
every patient for anxiety. We would like to encourage
future research investigating the influence of the treatment
of anxiety on the burden of CH.
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